A prospective study for introducing insulin pens and safety needles in a hospital setting. The SANITHY study

Antonio C. Bossi, Giovanni Veronesi, Carmine S. Poerio, Alessandra Braus, Sara Madaschi, Maurizio Destro, Bruno Ferraro, Lavinia Gilberti, Paolo Sganzerla, Estella M. Davis

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: to assess costs and safety of insulin pen devices and safety needles as compared to vial/syringes in hospitalized patients requiring insulin therapy in a General Hospital in Northern Italy. Materials and Methods: in a prospective 9-month study, consecutive patients admitted to three Hospital Units received insulin therapy through either a traditional disposable syringe method, or pen/safety needles with dual-ended protection, or disposable safety syringes. We compared the median direct (insulin and devices) and indirect (insulin supply at discharge, insulin wastage) costs of a 10-day in-hospital insulin treatment in the 3 study groups, additionally accounting for the costs related to the observed needlestick injury rate. Patients’ safety during in-hospital stay (hypo- and hyperglycemia episodes) and satisfaction were also assessed. Results: N=360 patients (55% men, mean age 75.6 years, 57% with DM since ≥10 years) were recruited in the study. Insulin pens had higher median direct cost than both traditional syringes (43 vs. 18 ϵ/patient, p<.0001) and safety syringes (21.5 ϵ/patient, p<.0001). However, when also indirect and injuries costs were taken into account, the estimated savings for using pens over traditional syringes were as high as 32 ϵ/patient (45.8 vs. 77.6 ϵ/patient, p-value <.0001). No differences in patients’ safety were observed. 74% and 12% of patients using pens and syringes would like to continue the method at home, respectively (p<0.0001). Discussion: A selective use of individual pre-filled pens/safety needles for patients who are likely to continue insulin therapy at home may strongly reduce hospital diabetes treatment related costs.

Original languageEnglish (US)
Pages (from-to)460-467
Number of pages8
JournalCurrent Diabetes Reviews
Volume12
Issue number4
DOIs
StatePublished - Dec 1 2016

Fingerprint

Needles
Syringes
Prospective Studies
Insulin
Safety
Costs and Cost Analysis
Patient Safety
Equipment Safety
Needlestick Injuries
Hospital Units
Penicillin G
Therapeutics
Hypoglycemia
General Hospitals
Hyperglycemia
Health Care Costs
Italy
Length of Stay
Equipment and Supplies
Wounds and Injuries

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

A prospective study for introducing insulin pens and safety needles in a hospital setting. The SANITHY study. / Bossi, Antonio C.; Veronesi, Giovanni; Poerio, Carmine S.; Braus, Alessandra; Madaschi, Sara; Destro, Maurizio; Ferraro, Bruno; Gilberti, Lavinia; Sganzerla, Paolo; Davis, Estella M.

In: Current Diabetes Reviews, Vol. 12, No. 4, 01.12.2016, p. 460-467.

Research output: Contribution to journalArticle

Bossi, AC, Veronesi, G, Poerio, CS, Braus, A, Madaschi, S, Destro, M, Ferraro, B, Gilberti, L, Sganzerla, P & Davis, EM 2016, 'A prospective study for introducing insulin pens and safety needles in a hospital setting. The SANITHY study', Current Diabetes Reviews, vol. 12, no. 4, pp. 460-467. https://doi.org/10.2174/1573399811666150806150210
Bossi, Antonio C. ; Veronesi, Giovanni ; Poerio, Carmine S. ; Braus, Alessandra ; Madaschi, Sara ; Destro, Maurizio ; Ferraro, Bruno ; Gilberti, Lavinia ; Sganzerla, Paolo ; Davis, Estella M. / A prospective study for introducing insulin pens and safety needles in a hospital setting. The SANITHY study. In: Current Diabetes Reviews. 2016 ; Vol. 12, No. 4. pp. 460-467.
@article{77456e16e90640b6a1d798b19e5d36b7,
title = "A prospective study for introducing insulin pens and safety needles in a hospital setting. The SANITHY study",
abstract = "Background: to assess costs and safety of insulin pen devices and safety needles as compared to vial/syringes in hospitalized patients requiring insulin therapy in a General Hospital in Northern Italy. Materials and Methods: in a prospective 9-month study, consecutive patients admitted to three Hospital Units received insulin therapy through either a traditional disposable syringe method, or pen/safety needles with dual-ended protection, or disposable safety syringes. We compared the median direct (insulin and devices) and indirect (insulin supply at discharge, insulin wastage) costs of a 10-day in-hospital insulin treatment in the 3 study groups, additionally accounting for the costs related to the observed needlestick injury rate. Patients’ safety during in-hospital stay (hypo- and hyperglycemia episodes) and satisfaction were also assessed. Results: N=360 patients (55{\%} men, mean age 75.6 years, 57{\%} with DM since ≥10 years) were recruited in the study. Insulin pens had higher median direct cost than both traditional syringes (43 vs. 18 ϵ/patient, p<.0001) and safety syringes (21.5 ϵ/patient, p<.0001). However, when also indirect and injuries costs were taken into account, the estimated savings for using pens over traditional syringes were as high as 32 ϵ/patient (45.8 vs. 77.6 ϵ/patient, p-value <.0001). No differences in patients’ safety were observed. 74{\%} and 12{\%} of patients using pens and syringes would like to continue the method at home, respectively (p<0.0001). Discussion: A selective use of individual pre-filled pens/safety needles for patients who are likely to continue insulin therapy at home may strongly reduce hospital diabetes treatment related costs.",
author = "Bossi, {Antonio C.} and Giovanni Veronesi and Poerio, {Carmine S.} and Alessandra Braus and Sara Madaschi and Maurizio Destro and Bruno Ferraro and Lavinia Gilberti and Paolo Sganzerla and Davis, {Estella M.}",
year = "2016",
month = "12",
day = "1",
doi = "10.2174/1573399811666150806150210",
language = "English (US)",
volume = "12",
pages = "460--467",
journal = "Current Diabetes Reviews",
issn = "1573-3998",
publisher = "Bentham Science Publishers B.V.",
number = "4",

}

TY - JOUR

T1 - A prospective study for introducing insulin pens and safety needles in a hospital setting. The SANITHY study

AU - Bossi, Antonio C.

AU - Veronesi, Giovanni

AU - Poerio, Carmine S.

AU - Braus, Alessandra

AU - Madaschi, Sara

AU - Destro, Maurizio

AU - Ferraro, Bruno

AU - Gilberti, Lavinia

AU - Sganzerla, Paolo

AU - Davis, Estella M.

PY - 2016/12/1

Y1 - 2016/12/1

N2 - Background: to assess costs and safety of insulin pen devices and safety needles as compared to vial/syringes in hospitalized patients requiring insulin therapy in a General Hospital in Northern Italy. Materials and Methods: in a prospective 9-month study, consecutive patients admitted to three Hospital Units received insulin therapy through either a traditional disposable syringe method, or pen/safety needles with dual-ended protection, or disposable safety syringes. We compared the median direct (insulin and devices) and indirect (insulin supply at discharge, insulin wastage) costs of a 10-day in-hospital insulin treatment in the 3 study groups, additionally accounting for the costs related to the observed needlestick injury rate. Patients’ safety during in-hospital stay (hypo- and hyperglycemia episodes) and satisfaction were also assessed. Results: N=360 patients (55% men, mean age 75.6 years, 57% with DM since ≥10 years) were recruited in the study. Insulin pens had higher median direct cost than both traditional syringes (43 vs. 18 ϵ/patient, p<.0001) and safety syringes (21.5 ϵ/patient, p<.0001). However, when also indirect and injuries costs were taken into account, the estimated savings for using pens over traditional syringes were as high as 32 ϵ/patient (45.8 vs. 77.6 ϵ/patient, p-value <.0001). No differences in patients’ safety were observed. 74% and 12% of patients using pens and syringes would like to continue the method at home, respectively (p<0.0001). Discussion: A selective use of individual pre-filled pens/safety needles for patients who are likely to continue insulin therapy at home may strongly reduce hospital diabetes treatment related costs.

AB - Background: to assess costs and safety of insulin pen devices and safety needles as compared to vial/syringes in hospitalized patients requiring insulin therapy in a General Hospital in Northern Italy. Materials and Methods: in a prospective 9-month study, consecutive patients admitted to three Hospital Units received insulin therapy through either a traditional disposable syringe method, or pen/safety needles with dual-ended protection, or disposable safety syringes. We compared the median direct (insulin and devices) and indirect (insulin supply at discharge, insulin wastage) costs of a 10-day in-hospital insulin treatment in the 3 study groups, additionally accounting for the costs related to the observed needlestick injury rate. Patients’ safety during in-hospital stay (hypo- and hyperglycemia episodes) and satisfaction were also assessed. Results: N=360 patients (55% men, mean age 75.6 years, 57% with DM since ≥10 years) were recruited in the study. Insulin pens had higher median direct cost than both traditional syringes (43 vs. 18 ϵ/patient, p<.0001) and safety syringes (21.5 ϵ/patient, p<.0001). However, when also indirect and injuries costs were taken into account, the estimated savings for using pens over traditional syringes were as high as 32 ϵ/patient (45.8 vs. 77.6 ϵ/patient, p-value <.0001). No differences in patients’ safety were observed. 74% and 12% of patients using pens and syringes would like to continue the method at home, respectively (p<0.0001). Discussion: A selective use of individual pre-filled pens/safety needles for patients who are likely to continue insulin therapy at home may strongly reduce hospital diabetes treatment related costs.

UR - http://www.scopus.com/inward/record.url?scp=84995572338&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84995572338&partnerID=8YFLogxK

U2 - 10.2174/1573399811666150806150210

DO - 10.2174/1573399811666150806150210

M3 - Article

VL - 12

SP - 460

EP - 467

JO - Current Diabetes Reviews

JF - Current Diabetes Reviews

SN - 1573-3998

IS - 4

ER -